| Literature DB >> 21676254 |
Till Töpfer1, Anita Gamauf, Elisabeth Haring.
Abstract
BACKGROUND: Natural history museums receive a rapidly growing number of requests for tissue samples from preserved specimens for DNA-based studies. Traditionally, dried vertebrate specimens were treated with arsenic because of its toxicity and insect-repellent effect. Arsenic has negative effects on in vivo DNA repair enzymes and consequently may inhibit PCR performance. In bird collections, foot pad samples are often requested since the feet were not regularly treated with arsenic and because they are assumed to provide substantial amounts of DNA. However, the actual influence of arsenic on DNA analyses has never been tested.Entities:
Year: 2011 PMID: 21676254 PMCID: PMC3138465 DOI: 10.1186/1756-0500-4-197
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Specimens of Garrulus glandarius included in this study
| year | feet | skin | taxon | NMW no. | lab no. |
|---|---|---|---|---|---|
| 1871 | 330 | 330 | 3.302 | Gglakry4 | |
| 1892 | 192 | 192 | 22.961 | Gglagla29 | |
| 1882 | 192 | 192 | 22.960 | Gglagla30 | |
| 1896 | 192 | 192 | 22.936 | Gglagla31 | |
| 1908 | 192 | 192 | 83.271 | Gglajap2 | |
| 1913 | 330 | 330 | 75.691 | Gglagla32 | |
| 1918 | 600 | 600 | 75.713 | Gglagla28 | |
| 1918 | 600 | 192 | 75.721 | Gglagla33 | |
| 1918 | 330 | 192 | 75.722 | Gglagla34 | |
| 1919 | 330 | 330 | 75.699 | Gglagla35 | |
| 1919 | 330 | 192 | 75.700 | Gglagla36 | |
| 1924 | 330 | 330 | 63.998 | Gglagla37 | |
| 1927 | 600 | 600 | 84.239 | Gglagla67 | |
| 1929 | 600 | 192 | 22.933 | Gglagla39 | |
| 1930 | 330 | 600 | 22.935 | Gglagla40 | |
| 1931 | 600 | 600 | 397 | Gglagla27 | |
| 1935 | 600 | 600 | 6.165 | Gglagla41 | |
| 1935 | 600 | 600 | 6.169 | Gglagla42 | |
| 1935 | 600 | 330 | 83.689 | Gglarho1 | |
| 1941 | 600 | 192 | 75.734 | Gglagla43 | |
| 1941 | 330 | 192 | 45.417 | Gglafas1 | |
| 1942 | 600 | 192 | 75.739 | Gglagla44 | |
| 1942 | 600 | 600 | 45.405 | Gglagla45 | |
| 1942 | 600 | 192 | 75.737 | Gglagla46 | |
| 1943 | 600 | 330 | 45.403 | Gglagla47 | |
| 1943 | 600 | 600 | 45.404 | Gglagla48 | |
| 1943 | 600 | 192 | 45.402 | Gglagla49 | |
| 1943 | 600 | 600 | 45.401 | Gglagla50 | |
| 1958 | 330 | 192 | 93.013 | Gglaruf1 | |
| 1959 | 330 | 192 | 93.540 | Gglagla25 | |
| 1961 | 600 | 330 | 86.271 | Gglagla26 | |
| 1962 | 600 | 192 | 93.015 | Gglaruf2 | |
| 1962 | 330 | 192 | 93.016 | Gglaruf3 | |
| 1967 | 600 | 600 | 72.179 | Gglagrc1 | |
| 1968 | 600 | 600 | 72.418 | Gglakry3 | |
| 1970 | 330 | 600 | 76.678 | Gglaatr1 | |
| 1972 | 600 | 330 | 72.606 | Gglagla17 | |
| 1975 | 600 | 600 | 73.118 | Gglagla18 | |
| 1981 | 600 | 192 | 78.428 | Gglagla19 | |
| 1981 | 600 | 600 | 78.427 | Gglagla20 | |
| 1981 | 600 | 330 | 78.459 | Gglagla21 | |
| 1983 | 600 | 600 | 78.462 | Gglagla22 | |
| 1983 | 330 | 330 | 78.460 | Gglagla23 | |
| 1983 | 600 | 600 | 78.493 | Gglagla51 | |
| 1983 | 600 | 600 | 78.495 | Gglagla52 | |
| 1983 | 600 | 600 | 78.494 | Gglagla53 | |
| 1983 | 600 | 600 | 78.469 | Gglagla54 | |
| 1983 | 600 | 600 | 78.467 | Gglagla55 | |
| 1983 | 600 | 600 | 78.468 | Gglagla56 | |
| 1983 | 600 | 600 | 78.475 | Gglagla57 | |
| 1983 | 600 | 600 | 78.473 | Gglagla58 | |
| 1983 | 600 | 600 | 78.474 | Gglagla59 | |
| 1983 | 600 | 600 | 78.472 | Gglagla60 | |
| 1983 | 600 | 600 | 78.478 | Gglagla61 | |
| 1983 | 600 | 600 | 78.479 | Gglagla62 | |
| 1983 | 600 | 600 | 78.477 | Gglagla63 | |
| 1985 | 600 | 600 | 81.225 | Gglagla64 | |
| 1985 | 600 | 192 | 81.226 | Gglagla24 | |
| 1987 | 600 | 600 | 84.076 | Gglagla65 | |
| 1988 | 600 | 600 | 82.614 | Gglagla66 | |
| 1989 | 600 | 600 | 75.732 | Gglagla38 | |
| 1990 | 600 | 600 | 85.916 | Gglagla68 | |
| 1990 | 600 | 330 | 85.917 | Gglagla69 | |
| 1990 | 600 | 600 | 85.915 | Gglagla70 | |
| 2002 | - | - | - | Gglagla6 | |
| 2002 | - | - | - | Gglagla8 | |
Rows "feet" and "skin" denote maximum amplicon lengths of foot pads and skin tissue samples, respectively. Samples Gglagla6 and Gglagla8 consist of fresh tissue material and were used as templates for PCR control and arsenic concentration experiments.
PCR primers used in this study
| Primer | Sequence (5'-3') | Source |
|---|---|---|
| CR-Cor14+ | GGAGTTATCTTCCTCTTGAC | Designed for this study |
| Phe-Cor- | TTGACATCTTCAGTGTCATGC | [ |
| CR-Cor13- | GGTGGTTTGGATAATGTAGGT | Designed for this study |
| CR-Cor12- | GAAACATGTCCGGCAACCAT | Designed for this study |
Overall PCR success of foot pad and body skin samples
| 192 bp | 330 bp | 600 bp | ||
|---|---|---|---|---|
| As-treated (n = 36) | 36 (100%) | 19 (53%) | 12 (33%) | |
| untreated (n = 28) | 28 (100%) | 26 (93%) | 22 (78%) | |
| total (n = 64) | 64 (100%) | 45 (70%) | 34 (53%) | |
| As-treated (n = 36) | 36 (100%) | 32 (89%) | 21 (58%) | |
| untreated (n = 28) | 28 (100%) | 28 (100%) | 27 (96%) | |
| total (n = 64) | 64 (100%) | 60 (94%) | 48 (75%) | |
| As-treated (n = 72) | 72 (100%) | 51 (71%) | 33 (46%) | |
| untreated (n = 56) | 56 (100%) | 54 (96%) | 49 (88%) | |
| total (n = 128) | 128 (100%) | 105 (82%) | 82 (64%) | |
Numbers of samples and percentage with successful PCR are given per sample type and amplicon length. Arsenic-treated samples are from the pre-1971 period.
Figure 1Overall PCR success. PCR success (in percent) of three mt CR amplicons. For each amplicon, total success and success per period (until 1971 & after 1971) is given. Grey columns - foot pads, empty columns - skin samples. Note that pre-1971 samples consist of arsenic-treated samples, post-1971 samples were untreated.
Figure 2Distribution of collection dates of successfully amplified samples. Only the maximum amplicon lengths are indicated. Black dots: foot pads, empty squares: skin samples. Some symbols may represent several samples from the same year with the same PCR success. The dashed line indicates the 1971 timeline after which the use of arsenic ceased.
Figure 3Influence of arsenic concentration on PCR performance. DNA template from fresh tissue sample Gglagla8. Arsenic concentrations (μg/μl): lanes 1-8: 0 - 4.6 - 4.8 - 5.0 - 5.2 - 5.4 - 6.0 - control sample (without DNA or arsenic). Signal intensity decreases with increasing arsenic concentration and breaks down from sample 6 (5.4 μg/μl).